311 related articles for article (PubMed ID: 17943249)
1. The translation of drug efficacy from in vivo models to human disease with special reference to experimental autoimmune encephalomyelitis and multiple sclerosis.
Bolton C
Inflammopharmacology; 2007 Oct; 15(5):183-7. PubMed ID: 17943249
[TBL] [Abstract][Full Text] [Related]
2. Virtues and pitfalls of EAE for the development of therapies for multiple sclerosis.
Steinman L; Zamvil SS
Trends Immunol; 2005 Nov; 26(11):565-71. PubMed ID: 16153891
[TBL] [Abstract][Full Text] [Related]
3. Steroid protection in the experimental autoimmune encephalomyelitis model of multiple sclerosis.
Garay L; Gonzalez Deniselle MC; Gierman L; Meyer M; Lima A; Roig P; De Nicola AF
Neuroimmunomodulation; 2008; 15(1):76-83. PubMed ID: 18667803
[TBL] [Abstract][Full Text] [Related]
4. Intravenous immunoglobulin treatment of multiple sclerosis and its animal model, experimental autoimmune encephalomyelitis.
Humle Jorgensen S; Sorensen PS
J Neurol Sci; 2005 Jun; 233(1-2):61-5. PubMed ID: 15949496
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic effects of combined treatment with ribavirin and tiazofurin on experimental autoimmune encephalomyelitis development: clinical and histopathological evaluation.
Stojkov D; Lavrnja I; Pekovic S; Dacic S; Bjelobaba I; Mostarica-Stojkovic M; Stosic-Grujicic S; Jovanovic S; Nedeljkovic N; Rakic L; Stojiljkovic M
J Neurol Sci; 2008 Apr; 267(1-2):76-85. PubMed ID: 17996253
[TBL] [Abstract][Full Text] [Related]
6. Amelioration of acute and relapsing stages of the experimental allergic encephalomyelitis by cobra toxins.
Mohamed A; Reid PF; Raymond L; Dufan T
Biomed Sci Instrum; 2006; 42():399-404. PubMed ID: 16817641
[TBL] [Abstract][Full Text] [Related]
7. Experimental allergic encephalomyelitis: a misleading model of multiple sclerosis.
Sriram S; Steiner I
Ann Neurol; 2005 Dec; 58(6):939-45. PubMed ID: 16315280
[TBL] [Abstract][Full Text] [Related]
8. Lessons from multiple sclerosis: models, concepts, observations.
Wekerle H
Ann Rheum Dis; 2008 Dec; 67 Suppl 3():iii56-60. PubMed ID: 19022815
[TBL] [Abstract][Full Text] [Related]
9. Antioxidant therapy in multiple sclerosis.
Mirshafiey A; Mohsenzadegan M
Immunopharmacol Immunotoxicol; 2009; 31(1):13-29. PubMed ID: 18763202
[TBL] [Abstract][Full Text] [Related]
10. Preclinical assessment of therapeutic antibodies against human CD40 and human interleukin-12/23p40 in a nonhuman primate model of multiple sclerosis.
't Hart BA; Hintzen RQ; Laman JD
Neurodegener Dis; 2008; 5(1):38-52. PubMed ID: 18075274
[TBL] [Abstract][Full Text] [Related]
11. Glucocorticoids in multiple sclerosis and experimental autoimmune encephalomyelitis.
Reichardt HM; Gold R; Lühder F
Expert Rev Neurother; 2006 Nov; 6(11):1657-70. PubMed ID: 17144780
[TBL] [Abstract][Full Text] [Related]
12. Experimental allergic encephalomyelitis animal models for analyzing features of multiple sclerosis.
Petry KG; Boullerne AI; Pousset F; Brochet B; Caillé JM; Dousset V
Pathol Biol (Paris); 2000 Feb; 48(1):47-53. PubMed ID: 10729911
[TBL] [Abstract][Full Text] [Related]
13. Clinical, pathological, and immunologic aspects of the multiple sclerosis model in common marmosets (Callithrix jacchus).
't Hart BA; Massacesi L
J Neuropathol Exp Neurol; 2009 Apr; 68(4):341-55. PubMed ID: 19337065
[TBL] [Abstract][Full Text] [Related]
14. EAE: pitfalls outweigh virtues of screening potential treatments for multiple sclerosis.
Ransohoff RM
Trends Immunol; 2006 Apr; 27(4):167-8. PubMed ID: 16513422
[No Abstract] [Full Text] [Related]
15. Elevation of matrix metalloproteinases (MMPs) in multiple sclerosis and impact of immunomodulators.
Yong VW; Zabad RK; Agrawal S; Goncalves Dasilva A; Metz LM
J Neurol Sci; 2007 Aug; 259(1-2):79-84. PubMed ID: 17382965
[TBL] [Abstract][Full Text] [Related]
16. Immunoglobulins treatment in multiple sclerosis and experimental autoimmune encephalomyelitis.
Achiron A; Miron S
Mult Scler; 2000 Oct; 6 Suppl 2():S6-8; discussion S33. PubMed ID: 11188777
[TBL] [Abstract][Full Text] [Related]
17. Thalidomide derivatives for the treatment of neuroinflammation.
Contino-Pépin C; Parat A; Patinote C; Roscoe WA; Karlik SJ; Pucci B
ChemMedChem; 2010 Dec; 5(12):2057-64. PubMed ID: 20936622
[TBL] [Abstract][Full Text] [Related]
18. An Iranian herbal-marine medicine, MS14, ameliorates experimental allergic encephalomyelitis.
Tafreshi AP; Ahmadi A; Ghaffarpur M; Mostafavi H; Rezaeizadeh H; Minaie B; Faghihzadeh S; Naseri M
Phytother Res; 2008 Aug; 22(8):1083-6. PubMed ID: 18570265
[TBL] [Abstract][Full Text] [Related]
19. Preliminary biological evaluations of new thalidomide analogues for multiple sclerosis application.
Contino-Pépin C; Parat A; Périno S; Lenoir C; Vidal M; Galons H; Karlik S; Pucci B
Bioorg Med Chem Lett; 2009 Feb; 19(3):878-81. PubMed ID: 19103485
[TBL] [Abstract][Full Text] [Related]
20. Glucocorticoids in the control of neuroinflammation.
Tischner D; Reichardt HM
Mol Cell Endocrinol; 2007 Sep; 275(1-2):62-70. PubMed ID: 17555867
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
